Ondine Biomedical Inc. NPV (CDI) (OBI)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

8.37p
   
  • Change Today:
    -0.13p
  • 52 Week High: 13.30
  • 52 Week Low: 5.63
  • Currency: UK Pounds
  • Shares Issued: 443.23m
  • Volume: 555
  • Market Cap: £37.10m
  • Beta: 0.01

Ondine appoints new finance, operations chief

By Josh White

Date: Wednesday 26 Feb 2025

LONDON (ShareCast) - (Sharecast News) - Ondine Biomedical announced the appointment of Michael Behlke as its chief financial and chief operating officer on Wednesday, strengthening its leadership team as the company advanced its commercialisation strategy.
The AIM-traded firm said Behlke would bring more than 30 years of financial and operational experience in the medical technology sector, having secured more than $250m in funding and facilitated acquisitions exceeding $700m.

Prior to joining Ondine, Behlke served as CFO and acting COO at Ventec Life Systems, where he oversaw the company's expansion from $13m to $500 million in annual revenue.

He reportedly played a key role in the company's partnership with General Motors to scale ventilator production for the US Strategic National Stockpile during the Covid-19 pandemic.

"Ondine is at a critical inflection point as we expand our hospital-based infection prevention solutions," said chief executive officer Carolyn Cross.

"Michael's extensive MedTech industry experience, operational leadership, and business transformation successes will be key to accelerating our worldwide commercialization efforts, initially within Canada, and the UK [and] EU, and then rapidly expanding into the US post-FDA approval."

In his new role at Ondine, the board said Behlke would oversee capital markets strategies, operational efficiency, and international expansion, ensuring the company was well-positioned for sustained growth and market leadership.

"I am honored to join Ondine at this pivotal moment," commented Michael Behlke.

"The company's groundbreaking photodisinfection technology represents a paradigm shift in infection control.

"I look forward to working with this talented team to drive operational excellence, financial growth, and global adoption of this life-saving technology."

Reporting by Josh White for Sharecast.com.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

OBI Market Data

Currency UK Pounds
Share Price 8.37p
Change Today -0.13p
% Change -1.53 %
52 Week High 13.30
52 Week Low 5.63
Volume 555
Shares Issued 443.23m
Market Cap £37.10m
Beta 0.01

OBI Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
69.69% below the market average69.69% below the market average69.69% below the market average69.69% below the market average69.69% below the market average
95.74% below the sector average95.74% below the sector average95.74% below the sector average95.74% below the sector average95.74% below the sector average
Price Trend
4.08% above the market average4.08% above the market average4.08% above the market average4.08% above the market average4.08% above the market average
27.66% above the sector average27.66% above the sector average27.66% above the sector average27.66% above the sector average27.66% above the sector average
Income Not Available
Growth
35.21% above the market average35.21% above the market average35.21% above the market average35.21% above the market average35.21% above the market average
41.94% above the sector average41.94% above the sector average41.94% above the sector average41.94% above the sector average41.94% above the sector average

OBI Dividends

No dividends found

Trades for 28-May-2025

Time Volume / Share Price
08:30 555 @ 9.00p

OBI Key Personnel

Chair Jean Charest
CEO Carolyn Cross

Top of Page